Endogenous mRNA is used to translate genetic information into functional proteins. Together with our collaboration partner ACCANIS we use in vitro transcribed (IVT), exogenously administered RNA that mimics natural mRNA, with modifications that improve its stability and translatability. Towards developing new RNA-based Therapies we are currently validating various therapeutic targets in skin explant cultures and different stem cell models

Aktivität: Sonstige wissenschaftliche AktivitätenKooperation


Publikationen, Drittmittel
Gehalten amAccanis Biotech F&E GmbH & Co KG